Danaher Corp (DHR)

Industry Diagnostics & Research

This stock can be held in an Investment ISA and an Investment Account

Sell

$184.62

Buy

$184.76

arrow-down$-3.13 (-1.67%)

Prices updated at 15 May 2025, 15:09 EDT

Prices minimum 15 mins delay

Prices in USD

Danaher Corp designs, manufactures and markets professional, medical, industrial and commercial products and services. It markets its products under the brand of Beckman Coulter, Aperio, Dexis, Chemtreat and others.

S&P 500

-0.3%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Diagnostics & Research

Chairman

Mr. Steven M. Rales

CEO

Mr. Rainer M. Blair

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

63,000

Head office

2200 Pennsylvania Avenue, North West

Washington

United States

20037-1701

+1 202 828-0850

investor.relations@danaher.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Charles W. Lamanna Independent Director	-
Mr. Alan G. Spoon, J.D. Independent Director	-
Ms. Linda Hefner Filler Lead Independent Director	0.19m
Mr. John T. Schwieters Independent Director	0.15m
Mr. Mitchell P. Rales Director	-
Mr. Steven M. Rales Chairman of the Board	-
Mr. Daniel A. Raskas Senior Vice President, Corporate Development	-
Dr. Elias A. Zerhouni, M.D. Independent Director	-
Ms. Teri L. List-Stoll Independent Director	0.13m
Mr. R. Bradley Gray Senior Vice President, Strategic Development	-
Mr. Matthew R. McGrew Executive Vice President and Chief Financial Officer	0.99m
Mr. Rainer M. Blair Director, President and Chief Executive Officer	1.35m
Mr. Brian W. Ellis Senior Vice President and General Counsel	0.80m
Dr. Jose-Carlos Gutierrez-Ramos, PhD Senior Vice President and Chief Scientific Officer	0.86m
Mr. Feroz Dewan Independent Director	-
Professor Raymond C. Stevens, PhD Independent Director	-
Dr. Jessica L. Mega, M.D.,M.P.H. Independent Director	0.13m
Mr. A. Shane Sanders Independent Director	-
Mr. Christopher M. Bouda Vice President and Chief Accounting Officer	-
Ms. Georgeann F. Couchara Senior Vice President, Human Resources	0.73m
Mr. Christopher Paul Riley Executive Vice President	-
Ms. Julie A. Sawyer Montgomery Executive Vice President	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Vanguard Group Inc	59,981,088
BlackRock Inc	52,602,194
State Street Corp	27,384,183
Wellington Management Company LLP	21,318,827
Vanguard Investments Australia Ltd	20,926,797

Director dealings

Date chevron-l-regular chevron-r-regular	Action
25 Nov 2024	-
26 Nov 2024	-
26 Nov 2024	-
26 Nov 2024	-
21 Nov 2024	-
21 Nov 2024	-
21 Nov 2024	-
15 Nov 2024	-
25 Oct 2024	-
25 Oct 2024	-
25 Oct 2024	-
25 Oct 2024	-
25 Oct 2024	-
25 Oct 2024	-
25 Oct 2024	-
25 Oct 2024	-
26 Aug 2024	-
01 Aug 2024	-
01 Aug 2024	-
01 Aug 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.